LLY Eli Lilly and Company
Healthcare · $1,240.34 · 52W $793.82–$1,292.65
Holders
12
Net buyers
+4
Held value
$13.2B
Above 52W low
56.2%
Holders12 Insider buys60 Past moves Open LLY financials →
✦

12 superinvestors hold LLY. In their latest filings 2 opened a position, 6 added and 4 trimmed; the biggest bet is PRIMECAP Management at 6.5% of their book.

Investor % of their book Value Shares Investor 1Y
PMPRIMECAP Management 6.51% $11.0B 9,172,904 Reduced −<1% +41.9%
Larry Robbins 1.26% $69.3M 57,771 New +46.1%
Eric Marshall 0.86% $12.9M 10,780 Added +25% +22.2%
Hersh Cohen 0.48% $580.0M 483,528 Added +4% +8.5%
Cliff Asness 0.43% $1.2B 1,035,605 Added +21% +25.8%
Mario Gabelli 0.29% $32.8M 27,377 Added +4% +13.5%
Stanley Druckenmiller 0.28% $14.8M 12,380 New +54.7%
Ron Baron 0.25% $168.6M 140,540 Added +65% -14.5%
Joel Greenblatt 0.06% $26.4M 21,971 Added +36% +14.0%
Murray Stahl 0.05% $4.6M 3,824 Reduced −4% -31.4%
D&Dodge & Cox 0.03% $49.5M 41,258 Reduced −2% +3.4%
Bill Nygren 0.00% $516,954 431 Reduced −4% +14.9%

Not investment advice. Data may be delayed or inaccurate.